{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T19:42:45Z","timestamp":1774640565098,"version":"3.50.1"},"reference-count":21,"publisher":"Spandidos Publications","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.3892\/ol.2016.4109","type":"journal-article","created":{"date-parts":[[2016,1,14]],"date-time":"2016-01-14T15:19:22Z","timestamp":1452784762000},"page":"1885-1888","source":"Crossref","is-referenced-by-count":5,"title":["Cytokine-induced killer cell therapy for the treatment of primary hepatocellular carcinoma subsequent to liver transplantation: A case report"],"prefix":"10.3892","volume":"11","author":[{"given":"RUNMEI","family":"LI","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"FANG","family":"YAN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"LIANG","family":"LIU","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"HUI","family":"LI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"BAOZHU","family":"REN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ZHENZHEN","family":"HUI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"XIUBAO","family":"REN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2016,1,14]]},"reference":[{"key":"key20180108094140_b1-ol-0-0-4109","first-page":"181","article-title":"Liver transplantation for hepatocellular carcinoma: Past, present and future","volume":"5","author":"Saidi","year":"2013","journal-title":"Middle East J Dig Dis"},{"key":"key20180108094140_b2-ol-0-0-4109","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/j.jhep.2011.05.012","article-title":"Criteria for liver transplantation for HCC: What should the limits be?","volume":"55","author":"Silva","year":"2011","journal-title":"J Hepatol"},{"key":"key20180108094140_b3-ol-0-0-4109","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1111\/j.1478-3231.2010.02425.x","article-title":"Impact of tumour differentiation to select patients before liver transplantation for hepatocellular carcinoma","volume":"31","author":"Decaens","year":"2011","journal-title":"Liver Int"},{"key":"key20180108094140_b4-ol-0-0-4109","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1245\/s10434-014-4273-6","article-title":"Benefit of treating hepatocellular carcinoma recurrence after liver transplantation and analysis of prognostic factors for survival in a large Euro-American series","volume":"22","author":"Sapisochin","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"key20180108094140_b5-ol-0-0-4109","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1200\/JCO.1999.17.1.324","article-title":"Recurrence patterns of hepatocellular and fibrolamellar carcinoma after liver transplantation","volume":"17","author":"Schlitt","year":"1999","journal-title":"J Clin Oncol"},{"key":"key20180108094140_b6-ol-0-0-4109","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1089\/cbr.2006.21.22","article-title":"Th1 bias in PBMC induced by multicycles of auto-CIKs infusion in malignant solid tumor patients","volume":"21","author":"Ren","year":"2006","journal-title":"Cancer Biother Radiopharm"},{"key":"key20180108094140_b7-ol-0-0-4109","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.3109\/14653240903121252","article-title":"Dendritic cell-activated cytokine-induced killer cells enhance the anti-tumor effect of chemotherapy on non-small cell lung cancer in patients after surgery","volume":"11","author":"Li","year":"2009","journal-title":"Cytotherapy"},{"key":"key20180108094140_b8-ol-0-0-4109","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1158\/1078-0432.CCR-11-2442","article-title":"Randomized study of autologous cytokine-induced killer cell immunotherapy in metastatic renal carcinoma","volume":"18","author":"Liu","year":"2012","journal-title":"Clin Cancer Res"},{"key":"key20180108094140_b9-ol-0-0-4109","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1007\/s00262-012-1260-2","article-title":"Autologous cytokine-induced killer cell immunotherapy in lung cancer: A phase II clinical study","volume":"61","author":"Li","year":"2012","journal-title":"Cancer Immunol Immunother"},{"key":"key20180108094140_b10-ol-0-0-4109","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1182\/blood-2007-06-092817","article-title":"In vivo trafficking and survival of cytokine-induced killer cells resulting in minimal GVHD with retention of antitumor activity","volume":"112","author":"Nishimura","year":"2008","journal-title":"Blood"},{"key":"key20180108094140_b11-ol-0-0-4109","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1046\/j.1365-2141.2002.03247.x","article-title":"Generation of cytokine-induced killer cells from leukaemic samples with in vitro cytotoxicity against autologous and allogeneic leukaemic blasts","volume":"116","author":"Linn","year":"2002","journal-title":"Br J Haematol"},{"key":"key20180108094140_b12-ol-0-0-4109","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/S0140-6736(00)02654-4","article-title":"Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: A randomised trial","volume":"356","author":"Takayama","year":"2000","journal-title":"Lancet"},{"key":"key20180108094140_b13-ol-0-0-4109","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.dld.2008.04.007","article-title":"A randomized, controlled trial of postoperative adjuvant cytokine-induced killer cells immunotherapy after radical resection of hepatocellular carcinoma","volume":"41","author":"Hui","year":"2009","journal-title":"Dig Liver Dis"},{"key":"key20180108094140_b14-ol-0-0-4109","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1096\/fasebj.12.11.939","article-title":"Intrahepatic proliferation of \u2018naive\u2019 and \u2018memory\u2019 T cells during liver allograft rejection: Primary immune response within the allograft","volume":"12","author":"Dollinger","year":"1998","journal-title":"FASEB J"},{"key":"key20180108094140_b15-ol-0-0-4109","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1517\/14712590903005552","article-title":"Cytokine induced killer cells as adoptive immunotherapy strategy to augment graft versus tumor after hematopoietic cell transplantation","volume":"9","author":"Sangiolo","year":"2009","journal-title":"Expert Opin Biol Ther"},{"key":"key20180108094140_b16-ol-0-0-4109","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1046\/j.1365-2141.2001.02906.x","article-title":"Non-MHC-restricted cytotoxic cells: Their roles in the control and treatment of leukaemias","volume":"114","author":"Lowdell","year":"2001","journal-title":"Br J Haematol"},{"key":"key20180108094140_b17-ol-0-0-4109","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/369031a0","article-title":"Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice","volume":"369","author":"K\u00e4gi","year":"1994","journal-title":"Nature"},{"key":"key20180108094140_b18-ol-0-0-4109","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/0092-8674(94)90376-X","article-title":"Cytotoxic lymphocytes require granzyme B for the rapid induction of DNA fragmentation and apoptosis in allogeneic target cells","volume":"76","author":"Heusel","year":"1994","journal-title":"Cell"},{"key":"key20180108094140_b19-ol-0-0-4109","first-page":"621414","article-title":"Growth of human colorectal cancer SW1116 cells is inhibited by cytokine-induced killer cells","volume":"2011","author":"Wang","year":"2010","journal-title":"Clin Dev Immunol"},{"key":"key20180108094140_b20-ol-0-0-4109","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.cellimm.2013.11.009","article-title":"Can the dual-functional capability of CIK cells be used to improve antitumor effects?","volume":"287","author":"Wang","year":"2014","journal-title":"Cell Immunol"},{"key":"key20180108094140_b21-ol-0-0-4109","doi-asserted-by":"crossref","first-page":"3493","DOI":"10.1182\/blood.V86.9.3493.bloodjournal8693493","article-title":"Two pathways of exocytosis of cytoplasmic granule contents and target cell killing by cytokine-induced CD3+CD56+ killer cells","volume":"86","author":"Mehta","year":"1995","journal-title":"Blood"}],"container-title":["Oncology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/ol.2016.4109\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,13]],"date-time":"2020-09-13T23:58:55Z","timestamp":1600041535000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/ol.2016.4109"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,14]]},"references-count":21,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2016,1,14]]},"published-print":{"date-parts":[[2016,3]]}},"alternative-id":["10.3892\/ol.2016.4109"],"URL":"https:\/\/doi.org\/10.3892\/ol.2016.4109","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,14]]}}}